2923-99-1Relevant articles and documents
COMPOUNDS AND COMPOSITIONS AS MODULATORS OF TLR SIGNALING
-
Paragraph 0406, (2020/10/20)
The present disclosure relates to compounds, pharmaceutical compositions comprising such compounds, and use of such compounds in methods of treatment or in medicaments for treatment of inflammatory diseases and certain neurological disorders that are related to inflammatory signaling processes, including but not limited to misfolded proteins.
MACROCYCLIC FACTOR VIIA INHIBITORS
-
Paragraph 00176, (2015/01/09)
The present invention provides compounds of Formula (I) as defined in the specification and compositions comprising any of such novel compounds. These compounds are Factor VIIa inhibitors which may be used as medicaments.